DWA
AVDL
Dorsey Wright & Associates’s Avadel Pharmaceuticals AVDL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-142,120
| Closed | -$1.86M | – | 131 |
|
2024
Q3 | $1.86M | Buy |
142,120
+16,215
| +13% | +$213K | 0.44% | 94 |
|
2024
Q2 | $1.77M | Sell |
125,905
-1,735
| -1% | -$24.4K | 0.46% | 94 |
|
2024
Q1 | $2.16M | Buy |
+127,640
| New | +$2.16M | 0.56% | 84 |
|
2015
Q4 | – | Sell |
-17,732
| Closed | -$289K | – | 108 |
|
2015
Q3 | $289K | Buy |
17,732
+3,212
| +22% | +$52.4K | 0.15% | 79 |
|
2015
Q2 | $287K | Buy |
14,520
+1,658
| +13% | +$32.8K | 0.14% | 82 |
|
2015
Q1 | $231K | Sell |
12,862
-27
| -0.2% | -$485 | 0.11% | 91 |
|
2014
Q4 | $221K | Buy |
12,889
+1,985
| +18% | +$34K | 0.1% | 105 |
|
2014
Q3 | $156K | Sell |
10,904
-809
| -7% | -$11.6K | 0.02% | 121 |
|
2014
Q2 | $160K | Buy |
11,713
+161
| +1% | +$2.2K | 0.02% | 137 |
|
2014
Q1 | $135K | Buy |
+11,552
| New | +$135K | 0.02% | 133 |
|